Drug Shortage Report for EPINEPHRINE INJECTION USP
Report ID | 66370 |
Drug Identification Number | 00721891 |
Brand name | EPINEPHRINE INJECTION USP |
Common or Proper name | EPINEPHRINE INJECTION USP |
Company Name | PFIZER CANADA ULC |
Market Status | MARKETED |
Active Ingredient(s) | EPINEPHRINE |
Strength(s) | 1MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRACARDIAC INTRAMUSCULAR INTRATRACHEAL INTRAVENOUS SUBCUTANEOUS |
Packaging size | 50 x 1mL AMP |
ATC code | C01CA |
ATC description | CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2018-11-30 |
Estimated end date | |
Actual end date | 2019-07-02 |
Shortage status | Resolved |
Updated date | 2019-07-03 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 17300 TRANS-CANADA HIGHWAY KIRKLAND, QUEBEC CANADA H9J 2M5 |
Company contact information | Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2018-11-07 | English | Compare |
v2 | 2018-11-07 | French | Compare |
v3 | 2018-11-28 | English | Compare |
v4 | 2018-11-28 | English | Compare |
v5 | 2018-11-28 | French | Compare |
v6 | 2018-12-01 | English | Compare |
v7 | 2019-01-21 | English | Compare |
v8 | 2019-01-21 | French | Compare |
v9 | 2019-01-24 | English | Compare |
v10 | 2019-01-24 | French | Compare |
v11 | 2019-03-27 | English | Compare |
v12 | 2019-03-27 | English | Compare |
v13 | 2019-03-27 | French | Compare |
v14 | 2019-04-08 | English | Compare |
v15 | 2019-04-08 | French | Compare |
v16 | 2019-06-10 | English | Compare |
v17 | 2019-06-10 | French | Compare |
v18 | 2019-07-03 | English | Compare |
v19 | 2019-07-03 | French | Compare |
Showing 1 to 19 of 19